TMDX - TransMedics Group Inc logo

TMDX

TransMedics Group Inc

9.3/10top 1%Revenue grew 100% of years5Y

TransMedics Group develops and commercializes the Organ Care System (OCS), a portable technology for organ preservation and monitoring, enabling improved transplantation of hearts, lungs, and livers for patients with end-stage organ failure.

โš•๏ธ Healthcare NASDAQ Listed 2019 $ USD
$1,000 invested 5 years ago โ†’$2,811today

Score Overview

1 Year
Score4.6
Net Growth-9.65%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth5.02%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score9.3
Net Growth488.84%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth20x
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Score7.6
Net Growth6x
Net Trend71%
Net Income ConsistencyInconsistent
Rev Growth25x
Rev TrendEvery year
Revenue Consistency94%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-05-21
$ 68.85โ€”
1 Year2025-05-21
$ 121.31-43.24%
5 Years2021-05-21
$ 24.49181.14%
All Time2019-05-02
$ 22.36207.92%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 635M$ 171M$ 461M
2025$ 605M$ 190M$ 488M
2024$ 441M$ 35M$ 336M
2023$ 241M-$ 25M$ 394M
2022$ 93M-$ 36M$ 201M
2021$ 30M-$ 44M$ 92M
2020$ 25M-$ 28M$ 125M
IPO2019$ 23M-$ 33M$ 80M